BETHLEHEM, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 second quarter financial results and certain business developments for 5:00 pm ET on Thursday, August 3, 2023.
A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately 90 days.
To participate in the live conference call, please follow the link below to pre-register. After registering, you will be provided with your access details via email.
https://register.vevent.com/register/BIa2ec244bbd894460808bcc1818c5136e
| Investor Contact: Jason Plagman VP, Investor Relations This email address is being protected from spambots. You need JavaScript enabled to view it. | Media Contact: Amy Koch Director, Corporate Communications This email address is being protected from spambots. You need JavaScript enabled to view it. |
| Last Trade: | US$3.71 |
| Daily Change: | -0.07 -1.85 |
| Daily Volume: | 792,191 |
| Market Cap: | US$276.730M |
December 19, 2024 November 06, 2024 August 06, 2024 | |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
